Dynavax appoints CEO Ryan Spencer as Interim CFO during CFO's maternity leave

DYNAVAX TECHNOLOGIES CORP

CFO Kelly MacDonald begins maternity leave April 1, 2024; expected return in early August 2024.
CEO Ryan Spencer appointed Interim CFO (principal financial officer) effective April 1, 2024.
No change in Spencer's compensation for assuming additional CFO duties.
Other officers assume some CFO duties; senior consultant with public company CFO experience hired.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Ryan Spencer

Interim Chief Financial Officer

DYNAVAX TECHNOLOGIES CORP

Effective: 2024-04-01
Filed: April 1, 2024, 7:59 PM ET

On March 29, 2024, Dynavax Technologies Corporation (the “Company”) appointed Ryan Spencer to serve in a temporary capacity as Interim Chief Financial Officer (principal financial officer) of the Company while Kelly MacDonald is on maternity leave, commencing April 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ryan Spencer was appointed as Interim Chief Financial Officer at DYNAVAX TECHNOLOGIES CORP.

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

On March 29, 2024, Dynavax Technologies Corporation (the “Company”) appointed Ryan Spencer to serve in a temporary capacity as Interim Chief Financial Officer (principal financial officer) of the Company while Kelly MacDonald is on maternity leave, commencing April 1, 2024.

View on SEC.gov

Source: SEC EDGAR

accession 0000950170-24-039305

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.